ZFIN Fish: nn1009aTg

ZFIN ID: ZDB-FISH-200326-19

ZFIN ID: ZDB-FISH-200326-19

Fish name:	nn1009aTg
Genotype:	nn1009aTg
Targeting Reagent:	none

HUMAN DISEASE MODELED by nn1009aTg

Human Disease	Conditions	Citations
liver cancer	standard conditions	Chou et al., 2018

GENE EXPRESSION
Gene expression in nn1009aTg

RNA expression

Expressed Gene	Structure	Conditions	Figures
ccnd1	liver	standard conditions	Fig. 5 from Chou et al., 2018
ccne1	liver	standard conditions	Fig. 3 from Chou et al., 2018
cdk1	liver	standard conditions	Fig. 3 from Chou et al., 2018
cdk2	liver	standard conditions	Fig. 3 from Chou et al., 2018
cdkn2a/b	liver	standard conditions	Fig. 5 from Chou et al., 2018
col1a1a	liver	standard conditions	Fig. S1 from Chou et al., 2018
ccn2a	liver	standard conditions	Fig. S1 from Chou et al., 2018
dgat2	liver	standard conditions	Fig. S1 from Chou et al., 2018
hpse	liver	standard conditions	Fig. S1 from Chou et al., 2018
mlxip	liver	standard conditions	Fig. S1 from Chou et al., 2018
mycb	liver	standard conditions	Fig. 5 from Chou et al., 2018
pap	liver	standard conditions	Fig. S1 from Chou et al., 2018
srebf1	liver	standard conditions	Fig. S1 from Chou et al., 2018

Protein expression

Antibody	Structure	Conditions	Figures
Ab13-ctnnb	liver	standard conditions	Fig. 5 from Chou et al., 2018
Ab2-pcna	liver	standard conditions	Fig. 3 from Chou et al., 2018
Ab9-mapk	liver nucleus	standard conditions	Fig. 4 from Chou et al., 2018

Reporter gene expression No data available

PHENOTYPE
Phenotype in nn1009aTg

Phenotype	Conditions	Figures
liver dysplastic, abnormal	standard conditions	Fig. 2 from Chou et al., 2018
liver fatty, abnormal	standard conditions	Fig. 1 , Fig. 2 from Chou et al., 2018
liver fibrotic, abnormal	standard conditions	Fig. 1 from Chou et al., 2018
liver hyperplastic, abnormal	standard conditions	Fig. 2 from Chou et al., 2018
liver hpse expression increased amount, abnormal	standard conditions	Fig. S1 from Chou et al., 2018
liver pap expression increased amount, abnormal	standard conditions	Fig. S1 from Chou et al., 2018
liver ab2-pcna labeling increased amount, abnormal	standard conditions	Fig. 3 from Chou et al., 2018
liver ab13-ctnnb labeling increased amount, abnormal	standard conditions	Fig. 5 from Chou et al., 2018
liver ccne1 expression increased amount, abnormal	standard conditions	Fig. 3 from Chou et al., 2018
liver col1a1a expression increased amount, abnormal	standard conditions	Fig. S1 from Chou et al., 2018
liver mlxip expression increased amount, abnormal	standard conditions	Fig. S1 from Chou et al., 2018
liver dgat2 expression increased amount, abnormal	standard conditions	Fig. S1 from Chou et al., 2018
liver cdk2 expression increased amount, abnormal	standard conditions	Fig. 3 from Chou et al., 2018
liver ccnd1 expression increased amount, abnormal	standard conditions	Fig. 5 from Chou et al., 2018
liver cdkn2a/b expression increased amount, abnormal	standard conditions	Fig. 5 from Chou et al., 2018
liver srebf1 expression increased amount, abnormal	standard conditions	Fig. S1 from Chou et al., 2018
liver cdk1 expression increased amount, abnormal	standard conditions	Fig. 3 from Chou et al., 2018
liver ccn2a expression increased amount, abnormal	standard conditions	Fig. S1 from Chou et al., 2018
liver mycb expression increased amount, abnormal	standard conditions	Fig. 5 from Chou et al., 2018
liver hepatocellular carcinoma present, abnormal	standard conditions	Fig. 2 from Chou et al., 2018
liver nucleus ab9-mapk labeling increased amount, abnormal	standard conditions	Fig. 4 from Chou et al., 2018

CITATIONS (1)